The blocking of IL-6 in the interaction of HIF-1α-expressed HCC cells and NK cells enhanced the NK cytotoxicity to cancer cells and the expression of activating receptors on NK cells (Fig. 2). Here, IL6 is linked to hepatocellular carcinoma.